The increasingly popular class of GLP-1 receptor and GIP dual medications, including tirzepatide, semaglutide, and the newly introduced retatrutide, represent promising advances in the treatment . Although https://copperpeptidesforskin408514.thekatyblog.com/41723280/tirzepatide-the-comparative-review